Vaccine major Serum Institute of India on Tuesday rejected charges that a COVID-19 vaccine candidate 'Covidshield' has serious side effects, adding that the incident with the Chennai volunteer is no way induced by the vaccine.
Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for "malicious" allegations.
A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs five crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial.
After holding a review meeting with Prime Minister Narendra Modi on Saturday, Serum Institute of India CEO Adar Poonawalla said that in the process of applying for emergency use authorization of Covishield in the next two weeks. He also said that there is an indication that the Centre may purchase 300-400 million doses by July 2021. "We are in the process of applying for emergency use authorization of Covishield in the next two weeks," Poonawala said.
Top News
Latest News
